Skip to content

Glutamine Popsicles in Bone Marrow Transplant (BMT)/Hematopoietic Stem Cell Transplant (HSCT) Patients

Evaluation of Glutamine Popsicles in Adult/Pediatric Bone Marrow Transplant (BMT)/Hematopoietic Stem Cell Transplant (HSCT) Patients

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00204958
Enrollment
50
Registered
2005-09-20
Start date
2004-02-29
Completion date
2007-05-31
Last updated
2015-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Marrow Transplantation, Hematopoietic Stem Cell Transplantion

Keywords

bone marrow transplant (BMT), hematopoietic stem cell transplant (HSCT)

Brief summary

Nutrition is an important part of the recovery process after having a head injury so that subjects can gain strength and fight off infection. Liquid nutrition formulas are often given to patients through a tube that has been placed into the intestines for feeding when they are unable to eat on their own. Some reports suggest that nutrition with extra amounts of the amino acid called glutamine may decrease infections and hospital stay in severely injured patients. The purpose of this study is to evaluate if giving extra amounts of an amino acid called glutamine with liquid nutrition formulas will decrease the risk of infection and length of stay in the intensive care unit after having a head injury.

Interventions

DRUGnutritional supplement
DRUGglutamine popsicle

Sponsors

University of Wisconsin, Madison
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
PREVENTION
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
4 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Males * Nonpregnant females * Receiving chemotherapy for BMT/HSCT

Exclusion criteria

* Documented hepatic dysfunction * History of cirrhosis * History of acute renal failure (creatinine clearance \< 25 mL/min) * Gastrointestinal malabsorptive disorder

Design outcomes

Primary

MeasureTime frame
grade of mucositis

Secondary

MeasureTime frame
need for intravenous versus oral nutritional supplementation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026